Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS
Cancer Treatment and Research Communications · 2026
DOI: 10.1016/j.ctarc.2026.101256 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Kayleigh Wilkins und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom. Electronic address: k.wilkins1@aston.ac.uk. Hauptthemen laut MEDLINE: Biomarkers, Tumor, RNA, Long Noncoding, Uterine Cervical Neoplasms. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Large loop excision of the transformation zone (LLETZ) is a common treatment for women who display grade 3 cervical intraepithelial neoplasia (CIN3). However, 78% of women report physical side effects and 71% of women report psychological effects after treatment. Furthermore, 76% of women report feeling rushed into the decision to undergo treatment, with no other monitoring option provided, highlighting the need for a less invasive monitoring procedure to be offered to patients. Long non-coding RNAs (LncRNAs) are non-coding RNA more than 200bp that display an abundance within serum. Previous research has associated the expression levels of several lncRNAs, such as Homeobox transcript antisense RNA (HOTAIR) and Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), with the commencement and progression of cervical cancer. This systematic review and meta-analysis aimed to evaluate the prognostic significance of HOTAIR and MALAT1 within the serum and tissue of cervical cancer patients. A literature search was conducted by three independent researchers spanning four databases. Using a PICOS inclusion and exclusion criteria, six identified studies (n=826) reported on the correlation between lncRNA expression and clinicopathological features in cervical cancer. HOTAIR or MALAT1 were significantly upregulated in cervical cancer patients compared to matched healthy participants (P =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom. Electronic address: k.wilkins1@aston.ac.uk.
- School of Biosciences, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom.
Zitieren
APA
Wilkins, K., David, O., Oguntoyinbo, J. O., Zainab, H., & Pallett, R. (2026). Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101256
Vancouver
Wilkins K, David O, Oguntoyinbo JO, Zainab H, Pallett R. Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101256
BibTeX
@article{Wilkins2026,
author = {Wilkins, Kayleigh and David, Olivia and Oguntoyinbo, Jonathan Openifoluwa and Zainab, Hira and Pallett, Ross},
title = {Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS},
journal = {Cancer Treatment and Research Communications},
year = {2026},
doi = {10.1016/j.ctarc.2026.101256}
}
EUVIMED